David Clark

David J.
Clark is currently a Member at The Royal College of Physicians and President at Pasteur Merieux MSD Ltd. He previously held positions such as President & Chief Executive Officer at Neose Technologies, Inc., MedImmune Vaccines, Inc., and Oncology.com, Inc. He also served as Chairman at Mersana Therapeutics, Inc. and TOLMAR Therapeutics, Inc., and as Executive Chairman at LigoCyte Pharmaceuticals, Inc. Additionally, he has held director positions at OraVax, Inc., FluGen, Inc., and NovaDigm Therapeutics, Inc. He worked as a Principal at Pfizer Inc. and GSK Plc, as well as at SmithKline Beecham Ltd. He has also served as Senior Vice President-Translational Medicine at VTVX Holdings I LLC from 2011 to 2013, Chief Medical Officer at Aldeyra Therapeutics, Inc. from 2016 to 2020, Chief Medical Officer at NormOxys, Inc. from 2009 to 2011, Chief Medical Officer at Wilson Therapeutics AB from 2013 to 2015, Chief Medical Officer at Allena Pharmaceuticals, Inc. from 2020 to 2022, and Chief Medical Officer at Trevi Therapeutics, Inc. from 2022 to 2024.
Dr. Clark obtained a doctorate degree from The University of Edinburgh in 1987.